about
Fractionation of Magnetic Microspheres in a Microfluidic Spiral: Interplay between Magnetic and Hydrodynamic Forces.One-pot syntheses, coordination, and characterization of application-specific biodegradable ligand-polymers.Influence of Iron Oxide Nanoparticles on Innate and Genetically Modified Secretion Profiles of Mesenchymal Stem CellsCrucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision"Effective Control of Molds Using a Combination of Nanoparticles.Integrated hollow microneedle-optofluidic biosensor for therapeutic drug monitoring in sub-nanoliter volumes.A micromechanical comparison of human and porcine skin before and after preservation by freezing for medical device development.Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.Nanoprobes for hybrid SPECT/MR molecular imaging.A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.Utilization of nanoparticles as X-ray contrast agents for diagnostic imaging applications.Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF).Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors.Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.Long-chain rhenium and technetium glucosamine conjugates.Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.Design, synthesis, and imaging of small amphiphilic rhenium and (99m)technetium tricarbonyl complexes.Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.Applications of magnetic targeting in diagnosis and therapy--possibilities and limitations: a mini-review.A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug.Simulation and experimental determination of the online separation of blood components with the help of microfluidic cascading spirals.Metal nanoparticles: understanding the mechanisms behind antibacterial activityRadiolabeling of biodegradable polymeric microspheres with [99mTc(CO)3]+ and in vivo biodistribution evaluation using MicroSPECT/CT imaging.90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer.Radiolabeling of magnetic targeted carriers (MTC) with indium-111.Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system.One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co.Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres.Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the 188Re tricarbonyl complex [188Re(CO)3(H2O)3]+.Accuracy of Rhenium-188 SPECT/CT activity quantification for applications in radionuclide therapy using clinical reconstruction methods.Tomographic magnetic particle imaging of cancer targeted nanoparticles.A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging.Accuracy, reproducibility, and uncertainty analysis of thyroid-probe-based activity measurements for determination of dose calibrator settings.Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.Long-circulating non-toxic blood pool imaging agent based on hyperbranched polyglycerols.
P50
Q30364061-C1BD5A3A-8107-48D2-BE44-2DEFD6B9D565Q33301147-2AC2CD3B-FC98-4492-BB9D-BD9FE6B19DF7Q33812258-A1FBECAC-D39B-49A1-B591-0808C0DA9775Q34130904-4CFEA7FF-AB52-41FB-9A25-35176997735BQ36259865-BA22A6A1-E77C-4ACC-9218-964B2B61E1E1Q37067667-C07C082A-66B7-45A6-AEE4-51876636C093Q37202553-6B16154B-0ECC-4BFE-A06B-39C5C9D39A2BQ37878121-62703E81-38FE-4399-9D79-CD3585E7FD2FQ38013146-7DC39F06-AC06-4EB0-9FCB-76F664F04A49Q38223948-350ABE25-BA77-4455-B0D1-7A38B1147994Q38232003-1223C525-084F-4329-B406-07C9CDC73DB5Q38570592-1CECDB06-BC0D-4953-AEDD-23D8542276BBQ38572888-6493F81F-0BBA-48CC-A4FD-29738CF6BF71Q38844101-BB9D63D8-0877-4003-ABC2-A022D3033C3CQ39440233-C4FEF63D-1539-44E4-B5AC-F3D23892B22FQ39489887-C2561568-1924-4538-800C-AC28CC5CC097Q39599382-EC965081-7B7D-40B8-AA3D-640DB977536FQ39706700-8849548D-34AF-4125-9A25-C33D34175F3EQ39706706-A79E0ED2-57DF-4842-BAAA-41ECA18383BCQ39795109-C9D152FF-DD11-424E-9907-7919E8007670Q39864925-A90E06B9-2B0C-4C1A-A55A-78B450E03817Q40204007-ED653E32-1656-4370-AFCB-A232CB52286EQ40655862-74D2EF0D-B9B5-4958-AFF2-11EB2E5B3D8CQ40903962-77954B41-34C3-4D0D-92E2-18493E7ABC25Q41814924-75B4BCE7-279E-4F88-89E6-89C0C0085FA5Q41991511-796426FE-823E-4CC0-A1CE-8F10B4AB4D85Q43500769-53D450D7-D5DE-49FF-97A8-AFDB97604459Q44433012-89529625-6911-433E-9640-00943810F289Q44589896-2613D2B5-732F-4F1E-9DEB-B18F68D61A78Q45189900-E80B47BF-878B-4406-8143-02182FC412C3Q45383583-0DF99989-5E57-4A38-BFC9-944DC950C48DQ46034689-02FF7198-43F3-4A10-8292-48D412B5D445Q46444213-60D7B1DD-4642-4327-B607-425D02ACF686Q47758659-1EEBC303-9DE7-4B41-8CCD-AB85823926A2Q47955292-1405B1FD-BCE8-453C-97DF-088CEA9A53F2Q47990343-08866420-F94C-47FB-9EC5-AF3F792CE3DEQ48118923-D31F4375-72C5-4417-A19D-4D436E120EA8Q48654988-C1B6E4D0-8F2F-4D06-A506-93D3E683400CQ49167961-1F08B1F7-1402-45BF-83C4-3CC92F6E1BB0Q50523678-B5EBA9C5-A769-4A9D-8244-7723E3B9BB7D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Urs O Häfeli
@es
Urs O. Häfeli
@en
Urs O. Häfeli
@nl
Urs O. Häfeli
@sl
type
label
Urs O Häfeli
@es
Urs O. Häfeli
@en
Urs O. Häfeli
@nl
Urs O. Häfeli
@sl
prefLabel
Urs O Häfeli
@es
Urs O. Häfeli
@en
Urs O. Häfeli
@nl
Urs O. Häfeli
@sl
P106
P1153
7003770170
P21
P31
P496
0000-0003-0671-4509
P569
2000-01-01T00:00:00Z